Medical/Pharmaceuticals
Smart Glove Lauded by Frost & Sullivan for Leading the Global Medical Gloves Industry with Pioneering Products and Creative Innovations
The company delivers a wide range of innovative and patented gloves to meet the growing demand worldwide. SAN ANTONIO, June 13, 2022 /PRNewswire/ -- Based on its recent analysis of the global medical gloves industry,Frost & Sullivan recognizes Smart Glove with the 2021 Technology Innovation Lead...
Meness Aptieka earns the Best Place to Work certification in Latvia for 2022
RIGA, Latvia, June 13, 2022 /PRNewswire/ -- Mēness Aptieka, one of the largest pharmacy brands inLatvia, has earned the best place to work certification in Latvia for its first participation. According to the assessment results, 81% of employees said that they are proud to work for the organizati...
Mentice AB explores the conditions for carrying out a directed share issue of approximately SEK 60 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTOTHE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UN...
DoctorOnCall and BUMITRA Malaysia Seal Partnership to Encourage Vaccination Amongst Hajj & Umrah Pilgrims
KUALA LUMPUR, Malaysia, June 13, 2022 /PRNewswire/ -- Malaysian digital health platform, Health Digital Technologies Sdn. Bhd. (DoctorOnCall) has inked a Memorandum of Understanding (MoU) with Bumiputera Tourism Operators Association ofMalaysia (BUMITRA Malaysia) to facilitate and increase health...
Kangpu Announces First Patient Dosed in the US Phase IIa Clinical Trial of NeoMIDES™ Molecular Glue KPG-818 in Systemic Lupus Erythematosus
SHANGHAI, June 12, 2022 /PRNewswire/ -- Kangpu Biopharmaceuticals, a clinical-stage company based inShanghai, China, announced today that the first patient has been dosed in the Company's US Phase IIa clinical trial of KPG-818, an orally bioavailable NeoMIDESTM molecular glue, for the treatment o...
General Homecare grows community of providers with the addition of NSW Home Support Services
* NSW Home Support Services joins General Homecare group * First non-Victorian brand to be part of General Homecare's "For locals, by locals" charter SYDNEY, June 13, 2022 /PRNewswire/ -- 30 May 2022, Melbourne. General Homecare, a leading homecare and Aged Care provider, has announced that N...
Ascletis Announces Appointment of Mr. John P. Gargiulo, Former North America President and CEO of Daiichi Sankyo, as Chief Business Officer
HANGZHOU, China and SHAOXING, China, June 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis"), today announces the expansion of management team with appointment of Mr.John P. Gargiulo, former North America President and CEO of Daiichi Sankyo, as Chief Business Officer. Mr.John ...
Innovent and IASO Bio Present Updated Data of BCMA CAR-T Cell Therapy (Equecabtagene Autoleucel) at EHA 2022
SAN FRANCISCO and SUZHOU, China, June 13, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
Innovent Releases Results of High-dose Cohorts in Phase 1 Clinical Study of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity at ENDO 2022
SAN FRANCISCO and SUZHOU, China, June 13, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and...
EHA 2022 | Ascentage Pharma Releases Encouraging Results of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Chinese Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
SUZHOU, China, and ROCKVILLE, MD, June 12, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released results from a Phase I study ...
Guojun Lang, CEO of Sanyou: New milestone in the establishment of super-trillion antibody libraries for antibody discovery of challenging targets
SHANGHAI, June 10, 2022 /PRNewswire/ -- Recently, Sanyou Biopharmaceuticals officially launched its independently developed Super-Trillion Antibody Libraries (STAL), and the concomitant innovative antibody drug discovery platform. Established by Sanyou after seven years of continuous innovation a...
EpiVax Poxvirus Vaccine Candidate Predicted to be Effective Against Monkeypox
PROVIDENCE, R.I., June 11, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces that it has developed VennVax,a smallpox vaccine candidate that is predicted to be highly effective against monkeypox. The development of this vaccine was funded by the National Institutes of Health (SBIR grant #R4...
Telix and RefleXion Expand Partnership for Prostate Cancer Treatment
MELBOURNE, Australia and INDIANAPOLIS, June 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RefleXion Medical, Inc. (Hayward, California, U.S.) (RefleXion) today announced the signing of a co-development and commercialisation agreement, to expand the use ...
Keymed Biosciences Announces Dosing of First Patient in Phase I Trial of Bispecific Antibody CM350
CHENGDU, China, June 10, 2022 /PRNewswire/ -- Keymed Biosciences (HKEX: 02162) announced today that the first patient has been dosed in the Phase I trial of CM350. CM350 is a GPC3xCD3 bispecific antibody developed by the Company for the treatment of solid tumors. The phase I trial is being conduc...
J INTS BIO successfully held two Korean Advisory Board Meetings for its Novel Oral 4th Generation EGFR TKI (JIN-A02)
Members include the 10 leading NSCLC experts in Korea, discussing clinical design and R&D… SEOUL, South Korea, June 10, 2022 /PRNewswire/ -- J INTS BIO announced that it had conducted two Korean Advisory Board Meetings (ABM), first inDecember 2021 and the second in April this year for its novel ...
Everest Medicines Announces Approval of Trodelvy® in China for Second-Line Metastatic Triple-Negative Breast Cancer
– Trodelvy is Everest's First Product to Receive Regulatory Approval in China – – Everest Plans to Launch Commercial Sales of Trodelvy in China in Q4 2022 – – Conference call will be held to discuss the approval– SHANGHAI, June 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", o...
Mentice AB completes a directed new share issue of approximately SEK 60 million which was significantly oversubscribed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTOTHE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, CHINA HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIB...
Mentice AB intends to acquire all assets related to the software solution Ankyras from the Spanish corporation Galgo Medical S.L.
STOCKHOLM, June 10, 2022 /PRNewswire/ -- Mentice AB (publ) ("Mentice" or the "Company"), a leading provider of high-tech solutions for decision support and productivity with the medical field of image guided interventional therapies, announces the intention to acquire all assets of the Ankyras so...
Inteleos Announces Maya Health Alliance as MissionPOCUS Selection for 2022
ROCKVILLE, Md., June 9, 2022 /PRNewswire/ -- Today Inteleos announced a pilot project withWuqu' Kawoq | the Maya Health Alliance as the selection of the Point-of-Care Ultrasound (POCUS) Certification Academy's 2022 MissionPOCUS™ project. As the fifth MissionPOCUS project since the initiative's in...
Inteleos Announces Maya Health Alliance as MissionPOCUS Selection for 2022
ROCKVILLE, Md., June 9, 2022 /PRNewswire/ -- Today Inteleos announced a pilot project withWuqu' Kawoq | the Maya Health Alliance as the selection of the Point-of-Care Ultrasound (POCUS) Certification Academy's 2022 MissionPOCUS™ project. As the fifth MissionPOCUS project since the initiative's in...
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 309 media titles]
2024-04-15 17:33AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 280 media titles]
2024-04-18 21:26Animated Life in Yunnan
[Picked up by 277 media titles]
2024-04-18 14:00